Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2024-06-12 00:00:00 ET · period of report 2024-06-10 · accession 0000950170-24-072426 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-12 | 2024-06-10 | RLAY | Rubin Jami | Dir | M - OptEx | $5.04 | +42.2K | 67.2K | +169% | +$212.9K |
| D | 2024-06-12 | 2024-06-10 | RLAY | Rubin Jami | Dir | M - OptEx | $0.00 | -42.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-10 | M | A | 42,242 | $5.04 | 67,242 | D | — | — | (F1) This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-10 | M | D | 42,242 | $0.00 | 0 | D | $5.04 · — to 2029-10-09 | 42,242 Common Stock | (F1) This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. (F2) This stock option vested in sixteen (16) equal quarterly installments following the vesting commencement date of October 10, 2019, subject to the reporting person's continued service relationship through each vesting date. |